Alcohol Excise Taxation, Tax Share and Revenue in the European Union and the United Kingdom in 2022: An Overview and Modelling Analysis
Drug and Alcohol Review · 2025
DOI: 10.1111/dar.70028 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug and Alcohol Review, 2025. Verfasst von Jürgen Rehm und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Canada. Hauptthemen laut MEDLINE: Taxes, Alcoholic Beverages, Alcohol Drinking. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAAA NIH HHS, National Institute on Alcohol Abuse and Alcoholism.
Abstract (Originalsprache)
Introduction
Although increases in alcohol excise taxation have been identified as one of the ‘best buys’ of the World Health Organization to reduce alcohol consumption and attributable harm, excise tax shares—the proportion of excise tax included in retail prices of alcoholic beverages—remain low in Europe. Revenue derived from alcohol excise taxation, and how it is affected by changes in alcohol excise taxation, has not yet been widely explored.
Methods
We conducted a search for revenues generated from alcohol excise taxation in all European Union (EU) countries and the United Kingdom between 2017 and 2022. We then calculated the average excise tax share for alcoholic beverages for 2022. Using regression analysis, we predict tax revenue per capita from the tax share, type of alcohol excise taxation, recorded and unrecorded consumption and prevalence of past‐year drinking. To illustrate the potential for revenue increases, we conducted a case study on Germany.
Results
In 2022, average revenue from alcohol excise taxation (119 euros per capita) and excise tax share (17.3%) were low in the EU countries and the United Kingdom, but showed sizable variation. The association between excise tax share and revenue from excise taxation was very high, with a Pearson correlation of 0.888 (0.720–0.958; df = 16; p < 0.0001). In regression analyses, only the excise tax share significantly predicted tax revenue. Discussion and Conclusions Marked revenue gains could be achieved in several countries having low tax shares by instituting increases in excise tax share, with only small effects on consumer prices.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Canada.
- Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Canada.
- PAHO/WHO Collaborating Centre at Centre for Addiction and Mental Health, Toronto, Canada.
- Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.
- Institute of Medical Science, Temerty Faculty of Medicine, C. David Naylor Building, Toronto, Canada.
- Department of Psychiatry, University of Toronto, Toronto, Canada.
ORCID-Profile: Jürgen Rehm, Ahmed S Hassan, Jakob Manthey
Förderung
- NIAAA NIH HHS
- National Institute on Alcohol Abuse and Alcoholism
Zitieren
APA
Rehm, J., Correia, D., Hassan, A. S., Manthey, J., Rovira, P., Shield, K. D., Ferreira-Borges, C., Neufeld, M., & Štelemėkas, M. (2025). Alcohol Excise Taxation, Tax Share and Revenue in the European Union and the United Kingdom in 2022: An Overview and Modelling Analysis. Drug and Alcohol Review. https://doi.org/10.1111/dar.70028
Vancouver
Rehm J, Correia D, Hassan AS, Manthey J, Rovira P, Shield KD, et al. Alcohol Excise Taxation, Tax Share and Revenue in the European Union and the United Kingdom in 2022: An Overview and Modelling Analysis. Drug and Alcohol Review. 2025. doi:10.1111/dar.70028
BibTeX
@article{Rehm2025,
author = {Rehm, Jürgen and Correia, Daniela and Hassan, Ahmed S and Manthey, Jakob and Rovira, Pol and Shield, Kevin D and Ferreira-Borges, Carina and Neufeld, Maria and Štelemėkas, Mindaugas},
title = {Alcohol Excise Taxation, Tax Share and Revenue in the European Union and the United Kingdom in 2022: An Overview and Modelling Analysis},
journal = {Drug and Alcohol Review},
year = {2025},
doi = {10.1111/dar.70028}
}
EUVIMED